Therapeutic siRNA: state of the art
ABSTRACT RNA interference (RNAi) is an ancient biological mechanism used to defend
against external invasion. It theoretically can silence any disease-related genes in a …
against external invasion. It theoretically can silence any disease-related genes in a …
Nucleic acid delivery for therapeutic applications
Recent medical advances have exploited the ability to address a given disease at the
underlying level of transcription and translation. These treatment paradigms utilize nucleic …
underlying level of transcription and translation. These treatment paradigms utilize nucleic …
Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR–Cas gene editing
CRISPR–Cas gene editing and messenger RNA-based protein replacement therapy hold
tremendous potential to effectively treat disease-causing mutations with diverse cellular …
tremendous potential to effectively treat disease-causing mutations with diverse cellular …
Extrahepatic targeting of lipid nanoparticles in vivo with intracellular targeting for future nanomedicines
T Nakamura, Y Sato, Y Yamada… - Advanced drug delivery …, 2022 - Elsevier
A new era of nanomedicines that involve nucleic acids/gene therapy has been opened after
two decades in 21st century and new types of more efficient drug delivery systems (DDS) …
two decades in 21st century and new types of more efficient drug delivery systems (DDS) …
Cancer nanomedicine: progress, challenges and opportunities
The intrinsic limits of conventional cancer therapies prompted the development and
application of various nanotechnologies for more effective and safer cancer treatment …
application of various nanotechnologies for more effective and safer cancer treatment …
'Passive'nanoparticles for organ-selective systemic delivery: design, mechanism and perspective
Nanotechnology has shown tremendous success in the drug delivery field for more effective
and safer therapy, and has recently enabled the clinical approval of RNA medicine, a new …
and safer therapy, and has recently enabled the clinical approval of RNA medicine, a new …
Barriers and strategies of cationic liposomes for cancer gene therapy
C Liu, L Zhang, W Zhu, R Guo, H Sun, X Chen… - … Therapy Methods & …, 2020 - cell.com
Cationic liposomes (CLs) have been regarded as the most promising gene delivery vectors
for decades with the advantages of excellent biodegradability, biocompatibility, and high …
for decades with the advantages of excellent biodegradability, biocompatibility, and high …
Emerging frontiers in drug delivery
Medicine relies on the use of pharmacologically active agents (drugs) to manage and treat
disease. However, drugs are not inherently effective; the benefit of a drug is directly related …
disease. However, drugs are not inherently effective; the benefit of a drug is directly related …
[HTML][HTML] Going beyond the liver: progress and challenges of targeted delivery of siRNA therapeutics
C Lorenzer, M Dirin, AM Winkler, V Baumann… - Journal of Controlled …, 2015 - Elsevier
Therapeutic gene silencing promises significant progress in pharmacotherapy, including
considerable expansion of the druggable target space and the possibility for treating orphan …
considerable expansion of the druggable target space and the possibility for treating orphan …
Efficient nanocarriers of siRNA therapeutics for cancer treatment
Nanocarriers as drug delivery systems are promising and becoming popular, especially for
cancer treatment. In addition to improving the pharmacokinetics of poorly soluble …
cancer treatment. In addition to improving the pharmacokinetics of poorly soluble …